Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 19/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SHBG | P04278 | 1/20 | 0.38 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.38 |
| ▸ | GUSB | P08236 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | G6PD | P11413 | 1/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3858743 | 0.79 | CYP19A1 (0.45) | CYP19A1 | |
| SCHEMBL901277 | 0.73 | CYP19A1 (0.44) | CYP19A1MEN1LMNASHBGSERPINA6 | |
| SCHEMBL4816897 | 0.71 | CYP19A1 (0.35) | CYP19A1 | |
| SCHEMBL4199872 | 0.70 | CYP19A1 (0.49) | CYP19A1 | |
| SCHEMBL12883279 | 0.69 | CYP19A1 (0.54) | CYP19A1 | |
| SCHEMBL17299248 | 0.69 | CYP19A1 (0.54) | CYP19A1 | |
| SCHEMBL9306491 | 0.69 | CYP19A1 (0.54) | CYP19A1MEN1LMNASHBGSERPINA6 | |
| SCHEMBL4584277 | 0.68 | CYP19A1 (1.00) | CYP19A1MEN1LMNASHBGSERPINA6 | |
| SCHEMBL9965232 | 0.68 | CYP19A1 (1.00) | CYP19A1MEN1LMNASHBGSERPINA6 | |
| SCHEMBL334388 | 0.68 | CYP19A1 (1.00) | CYP19A1MEN1LMNASHBGSERPINA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2029510-B1 | PATCHOULI ODORANT | FIRMENICH & CIE (CH) | 2013-07-17 | — | — | EP | disclosed |
| US-7592492-B2 | Contains perhydro-4-ethyl-8,8a-dimethyl-1-naphthalenol | FIRMENICH SA (CH) | 2009-09-22 | — | — | US | disclosed |
| US-20090130043-A1 | Contains perhydro-4-ethyl-8,8a-dimethyl-1-naphthalenol | FIRMENICH SA, PPON | 2009-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090130043-A1 | Contains perhydro-4-ethyl-8,8a-dimethyl-1-naphthalenol | CYP8B1, CPT1A, HPGD | CYP19A1 98/4885MEN1 3042/4885LMNA 2338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.